Babyganics Mineral Sunscreen Recalled for Failed Stability Specifications
Babyganics Sheer Blend SPF 50 Mineral Sunscreen is being recalled nationwide because ingredients separated during stability testing, prompting an FDA Class II recall.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving a product whose formulation failed stability specifications, with physical separation of ingredients observed. No illnesses or injuries have been reported; however, the defect in a sun-protective product represents a risk-of-harm situation where injury has not yet manifested.
Plain-English summary
Johnson, S.C. and Son, Inc., the manufacturer of Babyganics Sheer Blend SPF 50 Mineral Sunscreen Fragrance Free, has recalled 57,184 bottles distributed nationwide. The product comes in two sizes: 1.7 fl oz (50 mL) and 8 fl oz (236 mL) bottles.
The FDA classified this as a Class II recall after quality concerns were identified during routine stability monitoring. Testing revealed physical separation of ingredients, indicating the product failed stability specifications.
Consumers who have purchased this sunscreen should stop using it. Affected lot numbers include Lot #097C4/C080316 (expires 3/31/2026) for the 1.7 oz bottles and Lot #177K3/A303407 (expires 10/31/2025) for the 8 oz bottles. Contact the manufacturer or retailer for refund information.
The recalled product
- Product
- babyganics, Sheer Blend, SPF 50 Mineral Sunscreen Fragrance Free (zinc oxide 20%), a) 1.7 FL OZ (50 mL) bottle, UPC 810035921658, b) 8 FL OZ (236 mL) bottle, UPC 810035921382, Dist. by KAS Direct, LLC, 1525 Howe St., Racine, WI 53403, Made in Canada.
- Manufacturer
- Johnson, S C and Son, Inc
- Category
- Drug — Sunscreen
- Hazard
- ingredient-separation
- stability-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: a) 097C4/C080316
- Exp 03/31/2026
- b) 177K3/A303407
- Exp 10/31/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27